Health and Me on MSN

This widely used dementia drug may raise stroke risk in all patients, study finds

A large UK study of over 165,000 dementia patients finds risperidone raises stroke risk in all users, prompting concerns over ...

Widely Used Dementia Drug Raises Stroke Risk in All Patients

New safety study links sedative use to increased stroke risk. A large UK study involving more than 165,000 people with dementia has found that the drug risperidone increases the risk of stroke in all ...
Fierce Healthcare

LegalView Creates New Informational Practice Areas for Possibly Unsafe Drugs Risperdal and Dostinex

LegalView.com would like to inform readers of its newly launched information portal dealing with the possibly unsafe prescription drugs Dostinex and Risperdal. Each of these information portals ...
NJBIZ

Risperdal Gets Conditional Approval from FDA for New Uses

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. in Raritan says it has received an approvable letter from the Food and Drug Administration (FDA) for Risperdal (risperidone) to treat ...
Drug Store News

Teva intros generic Risperdal Consta

Risperidone for Extended-Release Injectable Suspension is used for the treatment of schizophrenia on its own or in combination with lithium or valproate for the maintenance treatment of Bipolar I ...
Nasdaq

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients ...

PARSIPPANY, N.J. & TEL AVIV, Israel & PARIS--(BUSINESS WIRE)-- Regulatory News: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell ...
Drug Store News

Amneal receives FDA nod for generic Risperdal Consta

Amneal has received the Food and Drug Administration’s approval of risperidone extended-release injectable suspension 12.5 mg/vial, 25 mg/vial, 37.5 mg/vial and 50 mg/vial, which is the generic of ...
Business Wire

UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the publication of efficacy ...
Nasdaq

Teva Pharmaceuticals Reports Positive Real-World Outcomes for UZEDY® (risperidone) in Schizophrenia Treatment Compared to Second-Generation Oral Antipsychotics

Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits. Teva Pharmaceuticals has announced positive ...
Reuters

FDA conditionally approves Risperdal for children

NEW YORK, June 21 (Reuters) - Johnson & Johnson on Thursday said U.S. regulators have given conditional approval for use of its drug Risperdal as a treatment for adolescents with schizophrenia and ...
Medscape

Risperidone Versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder

Patients. A total of 675 patients were involved in the ITT analysis (risperidone group, n = 349; conventional antipsychotic group, n = 326). The baseline demographics and the clinical characteristics ...